In immune checkpoint analysis, three immune checkpoint genes (HAVCR2, PDCD1LG2, SIGLEC15) were significantly different between high and low-risk groups of BLCA and normal adjacent tissues. Here, PDCD1LG2 is linked to bladder transitional cell carcinoma.